What is the efficacy of memantine in treating dementia in individuals with Down syndrome?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The evidence suggests that memantine does not significantly improve cognitive deficits associated with dementia in individuals with Down syndrome, based on current studies.

Fields of Study & Subjects

Down syndrome and intellectual disability research Dementia and Cognitive Impairment Research Alzheimer's disease research and treatments

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 March 2026
Language
EN